AMRS on NASDAQ

Amyris

Logo: Amyris, Public domain, via Wikimedia Commons3

Sustainable synthetic ingredients for consumer products.1

Price unavailable

Last updated Oct 16, 2026.

Overview

2003Founded1

Compare with AEMETIS, INC, Green Plains Renewable Energy or Gevo, Inc, or pick any stock.

  • TickerAMRS on NASDAQ1
  • IndustryIndustrial Organic Chemicals1
  • HeadquartersEmeryville1
  • Websitewww.amyris.com
  • Incorporated inDE4
  • Business address5885 Hollis Street, Suite 100, Emeryville, Ca 946084
  • Filer categoryAccelerated filer4

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-210.9%Operating margin5
-195.9%Net margin5
-21.1%Revenue growth, 20225

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue29¢$258.7M
  • Research and development12¢$110.2M
  • Selling, general and admin55¢$493.6M
  • Interest3¢$24.7M
  • Income tax0¢$2.7M

Out of $269.8M in revenue.5 The company lost money this year.

Financial statements

Revenue67895$269.8M in 2022+302% since 2016
0$100.0M$200.0M$300.0M$400.0M2016: $67.2M$67.2M20162017: $127.7M$127.7M2017+90%2018: $63.6M$63.6M2018−50%2019: $152.6M$152.6M2019+140%2020: $173.1M$173.1M2020+13%2021: $341.8M$341.8M2021+97%2022: $269.8M$269.8M2022−21%
Operating income67895-$569.0M in 2022+493% since 2016
-$600.0M-$400.0M-$200.0M02016: -$95.9M-$95.9M20162017: -$56.1M-$56.1M2017−42%2018: -$136.6M-$136.6M2018+144%2019: -$121.9M-$121.9M2019−11%2020: -$123.4M-$123.4M2020+1%2021: -$177.6M-$177.6M2021+44%2022: -$569.0M-$569.0M2022+220%
Net income67895-$528.5M in 2022+443% since 2016
-$600.0M-$400.0M-$200.0M02016: -$97.3M-$97.3M20162017: -$156.0M-$156.0M2017+60%2018: -$230.2M-$230.2M2018+48%2019: -$242.8M-$242.8M2019+5%2020: -$331.0M-$331.0M2020+36%2021: -$271.0M-$271.0M2021−18%2022: -$528.5M-$528.5M2022+95%
Fiscal year2016201720182019202020212022
Revenue$67.2M6$127.7M7$63.6M8$152.6M9$173.1M5$341.8M5$269.8M5
Cost of revenue$56.7M6$62.3M7$36.7M8$76.2M9$87.8M5$155.1M5$258.7M5
Research and development$51.4M6$57.6M7$68.7M8$71.5M9$71.7M5$94.3M5$110.2M5
Selling, general and admin$47.7M6$63.9M7$90.9M8$126.6M9$137.1M5$257.8M5$493.6M5
Operating income-$95.9M6-$56.1M7-$136.6M8-$121.9M9-$123.4M5-$177.6M5-$569.0M5
Interest$37.6M6$37.1M7$42.7M8$58.7M9$48.0M5$25.6M5$24.7M5
Income tax$553.0K6$6.9M7$08$629.0K9$293.0K5-$8.1M5-$2.7M5
Net income-$97.3M6-$156.0M7-$230.2M8-$242.8M9-$331.0M5-$271.0M5-$528.5M5
Earnings per share-$6.126-$2.896-$3.698-$2.679-$1.885-$0.935-$1.655
Earnings per share (diluted)-$6.556-$2.896-$3.698-$2.729-$1.885-$0.975-$1.695

Compare Amyris with another company

Former names

  • AMYRIS BIOTECHNOLOGIES INCMay 30, 2006 to May 25, 20104

Timeline

  1. Sep 28, 2010Went public Listed on NASDAQ1
  2. 2003Founded Founded1

Recent filings

  1. May 7, 20248-K
  2. May 7, 20244
  3. May 7, 20244
  4. May 7, 20244
  5. May 7, 20244
  6. May 7, 20244
  7. May 7, 20244
  8. May 7, 20244
  9. May 7, 20244
  10. May 7, 20244
  11. May 7, 20244
  12. Apr 23, 20248-K
  13. Apr 8, 20248-K
  14. Feb 28, 20248-K
  15. Feb 9, 20248-K

Every filing from the last three years, summarized. The full record is on SEC EDGAR.2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11